Paradigm of negative feedback via long-loop in the striatal dopamine release modulation in the rat;Paradigma de retroalimentación negativa vía circuito largo en la modulación de la liberación de dopamina en el estriado dorsal de la rata

Revista de Neurologia

Volumn 52, Issue 6, 2011, Pages 371-377

  Bueno Nava, Antonio ^a   González Piña, Rigoberto ^a   Ávila Luna, Alberto ^a   Alfaro Rodríguez, Alfonso ^a  

^a INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

Author keywords

Basal ganglia; Dopamine receptors; Dopamine release; Motor function; Negative feedback

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE;

BASAL GANGLION; DOPAMINE RELEASE; MOTOR PERFORMANCE; NEGATIVE FEEDBACK; NEUROMODULATION; NONHUMAN; REGULATORY MECHANISM; REVIEW; STRIATE CORTEX; ANIMAL; CORPUS STRIATUM; CYTOLOGY; FEEDBACK SYSTEM; GLOBUS PALLIDUS; HISTOLOGY; METABOLISM; MOTOR ACTIVITY; NERVE CELL; NERVE TRACT; PHYSIOLOGY; RAT; SUBSTANTIA NIGRA;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEEDBACK, PHYSIOLOGICAL; GLOBUS PALLIDUS; MOTOR ACTIVITY; NEURAL PATHWAYS; NEURONS; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA;

EID: 79953113379     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5206.2010417     Document Type: Review

References (45)

1. Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J Anat 2000; 196: 527-42. (Pubitemid 30458775)
2. Lanska DJ. Chapter 33: the history of movement disorders. Handb Clin Neurol 2010; 95: 501-46.
3. Zappia M, Nicoletti A, Muñoz-S D, Tapia-Núñez J. Reconsideraciones en el tratamiento de la enfermedad de Parkinson con levodopa: evidencias farmacodinámicas. Rev Neurol 2009; 49: 33-40.
4. Kreitzer AC, Malenka RC. Striatal plasticity and basal ganglia circuit function. Neuron Rev 2008; 60: 543-54.
5. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007; 30: 228-35.
6. Nicola SM, Surmeier DJ, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000; 23: 185-215. (Pubitemid 30350042)
7. Saklayen SS, Mabrouk OS, Pehek EA. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J Pharmacol Exp Ther 2004; 311: 342-8. (Pubitemid 39287814)
8. Wolf ME, Deutch AY, Roth RH. Pharmacology of central dopaminergic neurons. In Henn FA, DeLisi LE, eds. Handbook of schizophrenia. Vol. 2: Neurochemistry and neuropharmacology of schizophrenia. New York: Elsevier; 1987. p. 101-47.
9. Blanco-Lezcano L, Pavón-Fuentes N, Blanco-Lezcano V. Microdiálisis cerebral. Principales aplicaciones de la técnica. Rev Neurol 2001; 33: 464-70.
10. Palermo-Neto J. Dopaminergic systems. Dopamine receptors. Psychiatr Clin North Am 1997; 20: 705-21.
11. Schmitz Y, Benoit-Marand M, Gonon F, Sulzer D. Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 2003; 87: 273-89. (Pubitemid 37255235)
12. Westerink BH, Vries JB. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 1989; 99: 197-202. (Pubitemid 19098462)
13. Feuerstein TJ. Presynaptic receptors for dopamine, histamine, and serotonin. Handb Exp Pharmacol 2008; 184: 289-338.
14. Hervé D, Rogard M, Lévi-Strauss M. Molecular analysis of the multiple Golf alpha subunit mRNAs in the rat brain. Brain Res Mol Brain Res 1995; 32: 125-34.
15. Milligan G, Kostenis E. Heterotrimeric G-proteins: a short history. Br J Pharmacol 2006; 147 (Suppl 1): S46-55.
16. 3H] GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 1997; 80: 241-9.
17. 3H]-γ- aminobutyric acid from rat striatal slices. Br J Pharmacol 2001; 133: 165-71.
18. B receptors in mouse substantia nigra dopaminergic neurons in vivo. J Neurosci 2008; 28: 10386-98.
19. Bustos G, Abarca J, Campusano J, Bustos V, Noriega V, Aliaga E. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res Rev 2004; 47: 126-44. (Pubitemid 39574316)
20. Tomiyama K, Koshikawa N, Funada K, Oka K, Kobayashi M. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J Neurochem 1995; 65: 2790-5.
21. Imperato A, Di Chiara G. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 1988; 156: 385-93. (Pubitemid 18262832)
22. Zackheim JA, Abercrombie ED. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Brain Res Bull 2001; 54: 603-7.
23. Santiago M, Machado A, Cano J. Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists. Eur J Pharmacol 1993; 239: 83-91. (Pubitemid 23240144)
24. Abraini JH, Fechtali T, Rostain JC. Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study. Brain Res 1994; 642: 199-205. (Pubitemid 24105706)
25. Andersen PH, Jansen JA. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol 1990; 188: 335-47. (Pubitemid 20188391)
26. Nowak P, Dabrowska J, Bortel A, Biedka I, Szczerbak G, Słomian G, et al. Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. Eur J Pharmacol 2006; 552: 46-54. (Pubitemid 44648076)
27. Izquierdo-Claros RM, Boyano-Adánez MC, Larsson C, Gustavsson L, Arilla E. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum. Brain Res Mol Brain Res 1997; 47: 99-107.
28. Allen SM, Davis WM. Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch- Nyhan syndrome. Behav Pharmacol 1999; 10: 467-74. (Pubitemid 29440555)
29. Hersi AI, Rowe W, Gaudreau P, Quirion R. Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 1995; 69: 1067-74. (Pubitemid 3002650)
30. Keefe KA, Gerfen CR. Local infusion of the (+/-)-alpha-amino- 3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum. Neuroscience 1999; 89: 491-504. (Pubitemid 29044331)
31. Thomas WL Jr, Cooke ES, Hammer RP Jr. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation. J Pharmacol Exp Ther 1996; 278: 347-53. (Pubitemid 27167113)
32. Imperato A, Mulas A, Di Chiara G. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur J Pharmacol 1987; 142: 177-81. (Pubitemid 17159926)
33. Wilson CJ, Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci 1996; 16: 2397-410. (Pubitemid 26154349)
34. Floran B, Floran L, Sierra A, Aceves J. D2 receptor mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 1997; 237: 1-4. (Pubitemid 27521151)
35. Sotnikova T, Gainetdinov RR, Grekhova TV, Rayevsky KS. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study). Pharmacol Res 2001; 43: 283-90. (Pubitemid 32601436)
36. Jackson DM, Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994; 64: 291-369. (Pubitemid 24360282)
37. Burkhardt JM, Jin X, Costa RM. Dissociable effects of dopamine on neuronal firing rate and synchrony in the dorsal striatum. Front Integr Neurosci 2009; 3: 28.
38. Molloy AG, Waddington JL. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology (Berl) 1984; 82: 409-10. (Pubitemid 14138847)
39. Ferrer B, Gorriti MA, Palomino A, Gornemann I, De Diego Y, Bermúdez-Silva FJ, et al. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies. Eur J Pharmacol 2007; 559: 180-3. (Pubitemid 46295416)
40. Martín AB, Fernández-Espejo E, Ferrer B, Gorriti MG, Bilbao A, Navarro M, et al. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 2008; 33: 1667-79. (Pubitemid 351684717)
41. Kobayashi M, Iaccarino C, Saiardi A, Heidt V, Bozzi Y, Picetti R, et al. Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice. Proc Natl Acad Sci U S A 2004; 101: 11466-70.
42. Sokoloff P, Leriche L, Le Foll B. Dopamine receptors. Structure, function and implication in psychiatric disorders. In Gorwood P, Hamon M, eds. Psychopharmacogenetics. New York: Springer Science + Business Media; 2006. p. 357-419.
43. Hiroi N, Martín AB, Grande C, Alberti I, Rivera A, Moratalla R. Molecular dissection of dopamine receptor signaling. J Chem Neuroanat 2002; 23: 237-42. (Pubitemid 34606860)
44. Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry 2009; 66: 603-13.
45. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 1997; 19: 837-48. (Pubitemid 27471388)